Europe Ablation Devices Market size exceeded USD 2 million in 2021 and is projected to showcase around 10.7% growth rate between 2022 and 2028.

Ablation devices are medical equipment that is utilized during minimally invasive procedures to eliminate atypical tissues for therapeutic intervention. These devices use heat energy, radiofrequency, laser, or extreme cold to induce minor burns.

Get more details on this report - Request Free Sample PDF

The market growth is driven by the rising prevalence of cancers that leads to a surge in the number of ablation treatment procedures. Thus, a growing number of cancer patients is expected to accelerate the demand for ablation therapy thereby, propelling the adoption rate of ablation devices in the region. Moreover, the increasing geriatric population in the region that is prone to several chronic disorders will boost the market growth. Furthermore, the adoption of a sedentary lifestyle such as obesity, excessive alcohol and tobacco consumption, unhealthy dietary habits led to numerous diseases including cardiovascular disorders, cancer and others.

Ongoing technological developments in ablation therapy are another factor positively impacting the industry growth. Several market players are continuously involved in the development of advanced technologies is going to boost the market growth potential. Technologically advanced ablation devices are offering numerous advantages such as ease of use, enhanced accuracy, safety and efficacy.. Moreover, increasing awareness about the availability of advanced disease treatments coupled with growing government initiatives to enhance the accessibility of advanced treatment procedures for large patient pools are poised to fuel the industry outlook.  

Europe  Market, By Technology

The radiofrequency devices segment dominated around 49% market share in 2021, owing to procedural benefits including high success rate, ease of use, enhanced accessibility & availability along with cost-effectiveness and quick relief. Moreover, increasing patient preference towards minimally invasive procedures to treat several diseases will impel the market expansion. Also, the growing prevalence of chronic diseases in the region will stimulate the adoption rate.

Europe Market, By Application

The Europe ablation devices market from cardiology segment crossed USD 945 million revenue in 2021, due to the growing prevalence of several cardiovascular disorders such as atrial fibrillation and tachycardia. In addition, increasing adoption of several risk factors such as alcohol consumption, smoking and tobacco consumption, ingestion of certain drugs and high intake of caffeine is contributing to the growing incidence of cardiovascular diseases.

Europe Market, By End-use

Get more details on this report - Request Free Sample PDF

The hospitals segment held over 46% market share in 2021, attributed to the developed sophisticated healthcare infrastructure coupled with the integration of advanced technologies in the facilities. Moreover, expanding the network of hospitals across the European countries will enhance the accessibility to the advanced treatment therapies increasing patient inflow in the settings for ablation therapy will strengthen the market size.

An expanded network of hospitals across developing as well as developed European countries increases the treatment accessibility to patients in these settings. Thus, the companies are focusing on broadening technology availability in hospitals to cater to the huge patient population.

Europe Market, By Country

Germany ablation devices market accounted more than 21% revenue share in 2021, led by the growing elderly population. The geriatric population base is highly susceptible to numerous chronic diseases, thus contributing to the country’s disease burden. Moreover, increasing patient preference towards minimally invasive surgical treatments for a better outcome and minimal pain will spur the market demand. High adoption of advanced technology-enabled devices in healthcare facilities coupled with the availability of sophisticated infrastructure will positively impact the procedural rate.

Competitive Industry Landscape

Prominent participants operating across the Europe ablation devices market include Alcon Laboratories, Abbott Laboratories, AngioDynamics, Bausch & Lomb Incorporated, AtriCure, Inc, Biotronik SE & Co. KG, CONMED Corporation, Boston Scientific Corporation, Elekta AB, Varian, Medtronic plc, Olympus Corporation, and Ethicon, Inc (Johnson & Johnson). These companies are implementing several growth strategies such as collaborations, partnerships, acquisitions & mergers, product launches to gain a competitive edge over others.